Hims & Hers Health, Inc. Reports Strong Third Quarter Performance
Hims & Hers Health, Inc. (NYSE: HIMS), a recognized leader in the health and wellness sector, has reported its financial results for the third quarter, highlighting robust growth in its subscriber base and overall profitability. The company’s focus on providing tailored and affordable health solutions continues to drive impressive outcomes.
Record Subscriber Milestones
The company has now surpassed 2 million subscribers, with over 1 million engaged in personalized health solutions. According to Andrew Dudum, co-founder and CEO, this growth marks a significant milestone and underscores Hims & Hers' mission of improving health access across the nation.
Subscriber Growth and Brand Recognition
In a year-on-year comparison, Hims & Hers has experienced a dramatic 40% increase in subscribers, excluding contributions from its advanced GLP-1 solutions. This growth has been fueled by heightened brand awareness and personalized initiatives, as well as new customer acquisitions seeking multi-faceted healthcare solutions.
Third Quarter Financial Highlights
- Revenue: The company reported a remarkable revenue of $401.6 million for Q3 2024, a striking 77% increase from $226.7 million reported in the same quarter of 2023.
- Gross Margin: The gross margin percentage for Q3 2024 was recorded at 79%, reflecting a slight decrease from 83% in the same quarter last year.
- Net Income: Hims & Hers achieved a net income of $75.6 million for the quarter, benefiting from a tax-related gain, in stark contrast to a net loss of $(7.6) million a year earlier.
- Adjusted EBITDA: Reported at $51.1 million compared to $12.3 million in Q3 2023, demonstrating the effectiveness of the company's strategies.
- Free Cash Flow: The free cash flow for the quarter reached $79.4 million, a substantial leap from $19.3 million in the previous year.
Outlook for Future Growth
Looking ahead, Hims & Hers is optimistic about its continued growth trajectory, with forecasts suggesting revenue could reach between $1.460 billion and $1.465 billion for the full year.
Guidance for Upcoming Quarters
The company anticipates revenue in the range of $465 million to $470 million for the fourth quarter of 2024, along with an expected Adjusted EBITDA of $50 to $55 million, underscoring its commitment to achieving sustainable growth and profitability.
About Hims & Hers Health, Inc.
Hims & Hers is dedicated to transforming how individuals manage their health and wellness. By offering personalized solutions, the company aims to make healthcare accessible and user-friendly, ensuring that everyone can achieve their health aspirations.
Frequently Asked Questions
What were the key financial results for Hims & Hers in Q3 2024?
Hims & Hers achieved revenue of $401.6 million, a net income of $75.6 million, and an Adjusted EBITDA of $51.1 million, reflecting impressive growth.
How has subscriber growth impacted Hims & Hers?
Subscriber growth has exceeded 2 million, enhancing brand recognition and contributing significantly to revenue growth.
What is the future outlook for Hims & Hers?
The company projects a revenue range of $1.460 billion to $1.465 billion for the full fiscal year 2024 and anticipates continued growth.
What strategies are Hims & Hers implementing for growth?
Hims & Hers focuses on personalized healthcare solutions and expanding brand awareness to attract new customers.
Can you describe the company’s mission?
Hims & Hers aims to enhance health and wellness accessibility by providing tailored care solutions that meet individual needs.
